Risk of disability for US army personnel vaccinated against anthrax, 1998-2005

Vaccine

Volumn 29, Issue 35, 2011, Pages 6035-6041

  Sulsky, Sandra I ^a   Luippold, Rose S ^a   Garman, Patrick ^b   Hughes, Hayley ^b   Amoroso, Paul J ^c  

^a ENVIRON INTERNATIONAL CORPORATION   (United States)

^b Military Vaccine Agency   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Anthrax vaccine; Army; Disability

Indexed keywords

ANTHRAX VACCINE;

ADOLESCENT; ADULT; AGED; ARMY; ARTICLE; DISABILITY; DISABILITY SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEX DIFFERENCE; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTHRAX; ANTHRAX VACCINES; DISABILITY EVALUATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MILITARY PERSONNEL; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 79960707735     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.028     Document Type: Article

References (26)

1. Grabenstein J.D., Winkenwerder W. Bioterrorism and compulsory vaccination: United States continues vaccinating to keep troops healthy. BMJ 2004, 329(7472):977.
2. Grabenstein J.D., Pittman P.R., Greenwood J.T., Engler R.J. Immunization to protect the US Armed Forces: heritage, current practice, and prospects. Epidemiol Rev 2006, 28:3-26.
3. U.S. Department of Defense. Anthrax vaccine immunization program. [cited 2007, available from: URL: ]. http://www.anthrax.osd.mil/.
4. Enstone J.E., Wale M.C., Nguyen-Van-Tam J.S., Pearson J.C. Adverse medical events in British service personnel following anthrax vaccination. Vaccine 2003, 21(13-14):1348-1354.
5. Hayes S.C., World M.J. Adverse reactions to anthrax immunisation in a military field hospital. J R Army Med Corps 2000, 146(3):191-195.
6. Hunter D., Zoutman D., Whitehead J., Hutchings J., MacDonald K. Health effects of anthrax vaccination in the Canadian forces. Mil Med 2004, 169(10):833-838.
7. Lange J.L., Lesikar S.E., Rubertone M.V., Brundage J.F. Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, US Armed Forces, 1998-2000. Vaccine 2003, 21(15):1620-1628.
8. Mahan C.M., Kang H.K., Dalager N.A., Heller J.M. Anthrax vaccination and self-reported symptoms, functional status, and medical conditions in the National Health Survey of Gulf War Era Veterans and Their Families. Ann Epidemiol 2004, 14(2):81-88.
9. Martin S.W., Tierney B.C., Aranas A., Rosenstein N.E., Franzke L.H., Apicella L., et al. An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program. Pharmacoepidemiol Drug Saf 2005, 14(6):393-401.
10. Schumm W.R., Reppert E.J., Jurich A.P., Bollman S.R., Webb F.J., Castelo C.S., et al. Self-reported changes in subjective health and anthrax vaccination as reported by over 900 Persian Gulf War era veterans. Psychol Rep 2002, 90(2):639-653.
11. Wells T.S., Sato P.A., Smith T.C., Wang L.Z., Reed R.J., Ryan M.A. Military hospitalizations among deployed US service members following anthrax vaccination, 1998-2001. Hum Vaccin 2006, 2(2):54-59.
12. Wiesen A.R., Littell C.T. Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US army women. JAMA 2002, 287(12):1556-1560.
13. Ryan M.A., Smith T.C., Sevick C.J., Honner W.K., Loach R.A., Moore C.A., et al. Birth defects among infants born to women who received anthrax vaccine in pregnancy. Am J Epidemiol 2008, 168(Auguat (4)):434-442.
14. Sulsky S.I., Grabenstein J.D., Delbos R.G. Disability among U.S. army personnel vaccinated against anthrax. JOEM 2004, 46(10):1065-1075.
15. McNeil M.M., Chiang I.S., Wheeling J.T., Zhang Y. Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature. Pharmacoepidemiol Drug Saf 2007, 16(3):259-274.
16. Centers for Disease Control Surveillance for adverse events associated with anthrax vaccination-U.S. Department of Defense, 1998-2000. MMWR Morb Mortal Wkly Rep 2000, 49(16):341-345.
17. Niu M.T., Ball R., Woo E.J., Burwen D.R., Knippen M., Braun M.M. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. Vaccine 2009, 27(January (2)):290-297.
18. Smith B., Leard C.A., Smith T.C., Reed R.J., Ryan M.A. Anthrax vaccination in the Millennium Cohort: validation and measures of health. Am J Prev Med 2007, 32(4):347-353.
19. Amoroso P.J. Total army injury and health outcomes database: a model comprehensive research database. Mil Med 1999.
20. Lewis C., Suffet I.H., Hoggatt K., Ritz B. Estimated effects of disinfection by-products on preterm birth in a population served by a single water utility. Environ Health Perspect 2007, 115(February (2)):290-295.
21. Breslow N.E., Day N.E. Statistical methods in cancer research. The design and analysis of cohort studies 1987, vol. II. IARC Press, Lyon, France.
22. Sulsky S.I., Mundt K.A., Bigelow C., Amoroso P.J. Case-control study of discharge from the US army for disabling occupational knee injury: the role of gender, race/ethnicity, and age. Am J Prev Med 2000, 18(Suppl. 3):103-111.
23. Hosmer D.W., Lemeshow S. Applied survival analysis: regression modeling of time to event data 1999, Wiley, New York.
24. Rothman K., Greenland S., Lash T.L. Modern epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia. 3rd ed.
25. Bell N.S., Amoroso P.J., Williams J.O., Yore M.M., Engel C.C., Senier L., et al. Demographic, physical, and mental health factors associated with deployment of U.S army soldiers to the Persian Gulf. Mil Med 2000, 165(10):762-772.
26. Haley R.W. Point: bias from the " healthy-warrior effect" and unequal follow-up in three government studies of health effects of the Gulf War. Am J Epidemiol 1998, 148(August (4)):315-323.